Loading…
CIK 0001802528 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("fairmount-funds-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC | COM | $154.6M | 11.8%Prev: 7.3% | 2,048,647 SH | Increased |
| COGENT BIOSCIENCES INC | COM | $319.8M | 24.3%Prev: 11.6% | 9,003,418 SH | Increased |
| CRESCENT BIOPHARMA INC. | COM | $32.6M | 2.5%Prev: 1.5% | 2,747,866 SH | Increased+1,360,000 SH |
| DIANTHUS THERAPEUTICS INC | COM | $88.1M | 6.7%Prev: 11.7% | 2,137,191 SH | Decreased-1,170,000 SH |
| ENLIVEN THERAPEUTICS INC | COM | $57.2M | 4.4%Prev: 6.8% | 3,711,444 SH | Decreased |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $17.7M | 1.3%Prev: 0.9% | 8,625,000 SH | Increased+2,500,000 SH |
| JADE BIOSCIENCES INC | COM NEW | $70.3M | 5.3%Prev: 2.5% | 4,553,494 SH | Increased+1,333,126 SH |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | $54.4M | 4.1%Prev: 6.2% | 1,319,688 SH | Decreased-453,151 SH |
| NUVALENT INC | COM | $73.2M | 5.6%Prev: 5.7% | 727,563 SH | Increased |
| ORUKA THERAPEUTICS INC | COM | $112.3M | 8.5%Prev: 6.4% | 3,705,262 SH | Increased |
| SPYRE THERAPEUTICS INC | COM NEW | $131.6M | 10.0%Prev: 6.1% | 4,018,101 SH | Increased |
| VIRIDIAN THERAPEUTICS INC | COM | $121.8M | 9.3%Prev: 6.7% | 3,914,458 SH | Increased+454,545 SH |
| ZENAS BIOPHARMA INC | COM | $80.2M | 6.1%Prev: 3.8% | 2,209,025 SH | Increased+316,219 SH |
| 13F-HR |
| 0001104659-26-096405 |
| $1.51B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001104659-25-078521 | $771.9M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001104659-26-062419 | $1.38B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001104659-25-049337 | $644.6M | View |